In 2005, research identified the overexpression of ephrin-A3, ephrin-A4, EPHB2, EPHB3, and EPHB4 in ependymoma tumor cells, either from frozen or formalin-fixed tumor samples, but the clinical impact remains unclear [95]. This evidence concerns the gene EPHB2 and ependymoma.